Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0001179110-13-008511)

Filing Details

Accession Number:
0001179110-13-008511
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-05-15 21:24:10
Reporting Period:
2013-05-14
Filing Date:
2013-05-15
Accepted Time:
2013-05-15 20:24:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
919722 Astex Pharmaceuticals Inc ASTX Pharmaceutical Preparations (2834) 911841574
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1236365 J S James Manuso C/O Astex Pharmaceuticals, Inc.
4140 Dublin Boulevard, Suite 200
Dublin CA 94568		 Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-05-14 29,500 $4.03 35,900 No 4 M Direct
Common Stock Disposition 2013-05-14 29,500 $5.84 6,400 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Show Other Fields >>
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Director Stock Option (Right to buy) Disposition 2013-05-14 29,500 $0.00 29,500 $4.03
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2003-05-22 2013-05-22 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 70 Indirect See note
Footnotes
  1. Includes 60 shares held individually by spouse and 10 shares held by spouse as custodian for their daughter under the Uniform Grant to Minors Act.